AHK-Cu (100mg)
Technische Spezifikationen
| Reinheit (HPLC) | ≥98% (HPLC) |
| CAS-Nummer | 72957-37-0 |
| Form | White lyophilized powder |
| Lagerung | -20°C |
| Sequenz | Ala-His-Lys |
| Molekulargewicht | 340.38 g/mol |
| Salzform | Acetate |
| Löslichkeit | Soluble in water |
AHK-Cu (100mg)
EUR-Listenpreis · HU, SK, CZ, PL
- Eurozone (EUR)160,00 EUR
- Ungarn (HU)160,00 EUR≈ 64 000 Ft
- Slowakei (SK)160,00 EUR
- Tschechien (CZ)160,00 EUR≈ 4 000 Kč
- Polen (PL)160,00 EUR≈ 680,00 zł
Gleicher EUR-Listenpreis für Lieferung nach Ungarn, Slowakei, Tschechien und Polen. Abrechnung in EUR.
HUF/CZK/PLN sind indikativ aus EUR umgerechnet; die Slowakei nutzt EUR. Kurse annähernd. Abrechnung in EUR.
AHK-Cu 100 mg — größeres Format des Kupfer-Tripeptids für umfangreichere kosmetologische/Haarprotokolle. Nur RUO — ausschließlich für Laborforschung; nicht zum menschlichen Verzehr.
Ausschließlich für Laborforschung.
Nicht für den menschlichen Verzehr, tierärztliche oder diagnostische Zwecke.
From the Peptide Explorer
A copper-binding tripeptide closely related to GHK-Cu but with stronger selectivity for hair-follicle biology. Widely studied in cosmetic dermatology for promoting VEGF expression in dermal papilla cells, elongating the anagen phase of the hair cycle and improving follicular perfusion.
Key Mechanisms
- ›Copper(II) delivery to dermal tissue
- ›VEGF upregulation in dermal papilla cells
- ›Extension of the anagen (growth) phase
- ›Dermal microvascular angiogenesis
- ›Keratinocyte proliferation
Primary Research Areas
- ›Androgenic alopecia models
- ›Hair follicle cycling
- ›Dermal angiogenesis
- ›Scalp cosmetic research
Key Research Findings
- Induced VEGF expression and elongated anagen phase in dermal papilla cells (Pyo et al., 2007)
- Enhanced follicular cycling in isolated hair follicle organ culture
- Synergistic follicular effects when combined with GHK-Cu and biotinoyl tripeptide-1
Research Overview
A copper-binding tripeptide closely related to GHK-Cu but with stronger selectivity for hair-follicle biology. Widely studied in cosmetic dermatology for promoting VEGF expression in dermal papilla cells, elongating the anagen phase of the hair cycle and improving follicular perfusion.
Origin: Synthetic copper-binding tripeptide analogue of the naturally occurring GHK motif
Mechanism of Action
- Copper(II) delivery to dermal tissue
- VEGF upregulation in dermal papilla cells
- Extension of the anagen (growth) phase
- Dermal microvascular angiogenesis
- Keratinocyte proliferation
Primary Research Areas
- Androgenic alopecia models
- Hair follicle cycling
- Dermal angiogenesis
- Scalp cosmetic research
Key Published Findings
- Induced VEGF expression and elongated anagen phase in dermal papilla cells (Pyo et al., 2007)
- Enhanced follicular cycling in isolated hair follicle organ culture
- Synergistic follicular effects when combined with GHK-Cu and biotinoyl tripeptide-1
Research Protocol
Commonly studied routes: Topical, Subcutaneous. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
-20°C lyophilized; protect from light
Important Notice
AHK-Cu (100mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Forschungsspezifikationen
Synthesized for strict analytical consistency. Verified via HPLC/MS.Qualitätsstandards ansehen →
Handhabung & Lagerung
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water